A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR).
scientific article
Author/s
author: Paul E Brenchley, Pietro Canetta, Maria V Irazabal, Matthias Kretzler, Lada Beara-Lasic, Ellen T. McCarthy, Heather N. Reich, Daniel C. Cattran, Michelle Hladunewich, Brad H Rovin, Debbie S Gipson
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.